{"transactions":[{"id":992580,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Options (right to buy)","published_at":"2025-11-20T22:35:36.000Z","date":"2025-11-18","kind":"grant","planned":false,"acquired":true,"shares":200000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2026."}],"balance_after":200000,"derivative":{"exercise_price":13.53,"expiration_date":"2035-11-18","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001012975-25-000811","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000101297525000811/form4.xml","form_type":"4"}},{"id":1335783,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2024-12-11T22:17:43.000Z","date":"2024-12-09","kind":"grant","planned":false,"acquired":true,"shares":720000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in 16 substantially equal quarterly installments commencing on March 31, 2025."}],"balance_after":720000,"derivative":{"exercise_price":12.18,"expiration_date":"2034-12-09","underlying":"Common Stock","underlying_shares":720000},"source":{"system":"sec-edgar","filing":"0001062993-24-020462","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324020462/form4.xml","form_type":"4"}},{"id":1586936,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2024-03-08T21:12:19.000Z","date":"2024-03-06","kind":"grant","planned":false,"acquired":true,"shares":200004,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on March 6, 2025, March 6, 2026, and March 6, 2027."}],"balance_after":200004,"derivative":{"exercise_price":5.21,"expiration_date":"2034-03-06","underlying":"Common Stock","underlying_shares":200004},"source":{"system":"sec-edgar","filing":"0001062993-24-005969","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299324005969/form4.xml","form_type":"4"}},{"id":1808678,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Common Warrants (right to buy)","published_at":"2023-08-14T21:13:45.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":25907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":25907,"derivative":{"exercise_price":3.86,"exercise_date":"2023-08-11","expiration_date":"2028-08-11","underlying":"Common Stock","underlying_shares":25907},"source":{"system":"sec-edgar","filing":"0000899243-23-018119","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000089924323018119/doc4.xml","form_type":"4"}},{"id":1808677,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Common Stock","published_at":"2023-08-14T21:13:45.000Z","date":"2023-08-11","kind":"purchase","planned":false,"acquired":true,"shares":25907,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents shares of common stock, par value $0.0001 per share (the \"Common Stock\") purchased together with common warrants to purchase shares of Common Stock in the Issuer's registered underwritten offering on August 11, 2023 for a purchase price of $1.93."}],"balance_after":25907,"source":{"system":"sec-edgar","filing":"0000899243-23-018119","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000089924323018119/doc4.xml","form_type":"4"}},{"id":1854534,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2023-06-15T20:13:33.000Z","date":"2023-06-13","kind":"grant","planned":false,"acquired":true,"shares":153000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on June 13, 2024, June 13, 2025, and June 13, 2026."}],"balance_after":153000,"derivative":{"exercise_price":0.23,"expiration_date":"2033-06-13","underlying":"Common Stock","underlying_shares":153000},"source":{"system":"sec-edgar","filing":"0001062993-23-013639","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299323013639/form4.xml","form_type":"4"}},{"id":2948836,"issuer":{"id":5596,"kind":"organization","name":"Benitec Biopharma Inc."},"owners":[{"id":72821,"kind":"person","name":"Boston Megan","position":1,"cik":"0001808923","reported_name":"Boston Megan","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Executive Director"}}],"security":"Options (right to buy)","published_at":"2020-12-11T21:53:29.000Z","date":"2020-12-09","kind":"grant","acquired":true,"shares":142172,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock options will vest in three substantially equal installments on December 9, 2021, December 9, 2022, and December 9, 2023."}],"balance_after":142172,"derivative":{"exercise_price":2.98,"expiration_date":"2030-12-09","underlying":"Common Stock","underlying_shares":142172},"source":{"system":"sec-edgar","filing":"0001062993-20-006255","document":"form4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1808898/000106299320006255/form4.xml","form_type":"4"}}]}